Literature DB >> 23672242

Pseudomonas aeruginosa post-operative peritonitis: clinical features, risk factors, and prognosis.

Pascal Augustin1, Alexy Tran-Dinh, Nadia Valin, Mathieu Desmard, Marie Adeline Crevecoeur, Claudette Muller-Serieys, Paul-Louis Woerther, Jean-Pierre Marmuse, Regis Bronchard, Philippe Montravers.   

Abstract

BACKGROUND: Postoperative peritonitis (PP) is associated with a high rate of multi-drug-resistant micro-organisms. The role of Pseudomonas aeruginosa in this condition has never been assessed. We evaluated the risk factors and prognosis for PP caused by P. aeruginosa.
METHODS: Patients hospitalized in the intensive care unit (ICU) after re-operation for PP were identified prospectively. Analyses were performed retrospectively. Specific risk factors were investigated by comparing P. aeruginosa PP with PP having other causes. The main outcome endpoint was death in the hospital.
RESULTS: We found 55 P. aeruginosa PP among the 349 cases of PP (16%) in the ICU over 14 years. Factors associated with the presence of P. aeruginosa in peritoneal fluid culture were Acute Physiology and Chronic Health Evaluation (APACHE) II score (odds ratio [OR] 1.1; 95% confidence interval [CI] 1.02-1.09; p=0.004) and respiratory failure (OR 2.3; 95% CI 1.26-4.16; p=0.006). These criteria performed poorly in predicting P. aeruginosa PP. Such infections were associated with a higher hospital mortality rate, but not after adjustment for the severity score. Adequate antibiotic therapy comprising two antibiotics effective against P. aeruginosa was associated with a lower mortality rate for P. aeruginosa PP in the ICU.
CONCLUSION: The prevalence of P. aeruginosa PP is not high. Risk factors do not allow accurate prediction of the infection. Our data suggest two drugs effective against P. aeruginosa should be considered for treating these infections.

Entities:  

Mesh:

Year:  2013        PMID: 23672242     DOI: 10.1089/sur.2012.084

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  9 in total

1.  Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study.

Authors:  Benjamin Miller; Myra W Popejoy; Ellie Hershberger; Judith N Steenbergen; John Alverdy
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.

Authors:  Philippe Montravers; Florence Tubach; Thomas Lescot; Benoit Veber; Marina Esposito-Farèse; Philippe Seguin; Catherine Paugam; Alain Lepape; Claude Meistelman; Joel Cousson; Antoine Tesniere; Gaetan Plantefeve; Gilles Blasco; Karim Asehnoune; Samir Jaber; Sigismond Lasocki; Herve Dupont
Journal:  Intensive Care Med       Date:  2018-02-26       Impact factor: 17.440

3.  Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis.

Authors:  Philippe Montravers; Guillaume Dufour; Jean Guglielminotti; Mathieu Desmard; Claudette Muller; Hamda Houissa; Nicolas Allou; Jean-Pierre Marmuse; Pascal Augustin
Journal:  Crit Care       Date:  2015-03-02       Impact factor: 9.097

4.  Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

Authors:  Joseph Solomkin; Ellie Hershberger; Benjamin Miller; Myra Popejoy; Ian Friedland; Judith Steenbergen; Minjung Yoon; Sylva Collins; Guojun Yuan; Philip S Barie; Christian Eckmann
Journal:  Clin Infect Dis       Date:  2015-02-10       Impact factor: 9.079

5.  Outcome of community- versus hospital-acquired intra-abdominal infections in intensive care unit: a retrospective study.

Authors:  Timothée Abaziou; Fanny Vardon-Bounes; Jean-Marie Conil; Antoine Rouget; Stéphanie Ruiz; Marion Grare; Olivier Fourcade; Bertrand Suc; Marc Leone; Vincent Minville; Bernard Georges
Journal:  BMC Anesthesiol       Date:  2020-12-01       Impact factor: 2.217

6.  Novel Multiparametric Nomogram for Overall Survival Prediction in Complicated Intra-Abdominal Infection: A Multicenter Study in China.

Authors:  Sisi Huang; Limin Chen; Jiao Liu; Sheng Zhang; Lidi Zhang; Zhenliang Wen; Yizhu Chen; Dechang Chen
Journal:  Front Med (Lausanne)       Date:  2021-02-22

7.  Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases.

Authors:  Jin Gao; Xinyue Dong; Yujie Su; Zhenjia Wang
Journal:  Acta Biomater       Date:  2021-01-18       Impact factor: 8.947

Review 8.  Perioperative Antibiotic Prophylaxis and Antimicrobial Therapy of Intra-Abdominal Infections.

Authors:  Stefan Hagel; Hubert Scheuerlein
Journal:  Viszeralmedizin       Date:  2014-10-06

9.  Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study.

Authors:  A Gomila; J Carratalà; J M Badia; D Camprubí; M Piriz; E Shaw; V Diaz-Brito; E Espejo; C Nicolás; M Brugués; R Perez; A Lérida; A Castro; S Biondo; D Fraccalvieri; E Limón; F Gudiol; M Pujol
Journal:  BMC Infect Dis       Date:  2018-10-05       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.